From Funding to Regulation: The Talent Challenges Reshaping Digital Health.

Digital Health Funding Rebounded into Fewer Hands

The funding winter is over, though the thaw is uneven. US digital health startups raised 7.4 billion dollars across 244 deals in the first half of 2026, according to Rock Health , roughly a billion ahead of the same period last year.

Look closer and the capital is bunching. A small group of megadeals took most of the oxygen, among them WHOOP at 575 million dollars, Verily Health at 300 million and OpenEvidence at 250 million. Mental health stayed the most funded clinical area, with weight management close behind on the back of the GLP-1 surge. AI runs underneath all of it, quietly resetting what investors expect a company to achieve with a given headcount.

For hiring, that concentration matters more than the headline number. Money is pooling in scaled platforms and AI-native tools, so the roles are pooling there too. The seed-stage generalist market is thinner. The scale-up market for people who can commercialise a proven product is not.

Healthtech’s M&A Wave Is Rewriting the Talent Brief

One of the clearest signals in the market recently was not a funding round. It was an acquisition. Sword Health agreed to acquire Headspace in an all-cash deal, joining Sword's AI-driven musculoskeletal platform to the best-known name in consumer mental health.

Read it as a direction of travel. Buyers are tired of stitching point solutions together, and the winners are assembling integrated platforms that do more under one roof. athenahealth rolling more than eighty new and expanded AI features into its revenue-cycle platform is the same story told in product terms.

When platforms consolidate, value shifts to the people who make the pieces work together. Integration-minded product managers get harder to find. Customer Success stops being a support function and becomes the reason a merged platform keeps the customers it just paid for.

AI Is Expanding the Regulatory Surface Faster Than Teams Can Staff It

If your software touches a clinical decision, your regulatory surface grew this year, on both sides of the Atlantic.

In the US, the FDA finalised its Clinical Decision Support guidance in January and its medical-device cybersecurity guidance in February, while its Predetermined Change Control Plan pathway now lets an approved model update within agreed limits without a fresh submission. The one everyone is waiting on, the total product lifecycle guidance for AI-enabled devices, was still in draft over the summer.

In the UK, the MHRA published its AI Airlock Phase 2 report in June and secured Department of Health and Social Care funding of 1.2 million pounds a year through to 2029 for Phase 3. The Airlock is Britain's sandbox for AI as a medical device, and Phase 2 worked through the questions that keep quality teams awake: adaptive models that change after approval, diagnostic AI and post-market surveillance for drift.

This is where the hiring signal is loudest and least understood. Every one of these developments creates demand for a specific and scarce person: someone who can hold a conversation about a model and a conversation about a regulator in the same breath. We're increasingly seeing searches that would previously have focused purely on regulatory or quality experience now require candidates to understand AI/ML development, adaptive algorithms and post-market model monitoring. A brilliant algorithm sitting behind an empty regulatory function is a product that cannot ship.

Healthtech’s Quietest Failure Happens at Renewal

But getting a product through regulation is only half the challenge. The other is getting people to actually use it. 

A recent Pew Research Center survey of nearly 3,500 US adults found that 53 percent feel they have little or no say over whether AI is used in their care, and only 17 percent feel they have a real one (Pew Research Center, 2026). Sit with that. A company can clear the FDA, raise its round and still lose, because the people on the receiving end were never brought along. Adoption is the quiet killer in digital health, and it does not show up on a product roadmap.

The pattern our desk sees is consistent. The market treats Customer Success as the team you bolt on once the contracts are signed, when it is the team that decides whether those contracts renew. The role has changed underneath everyone. A modern healthtech CSM has to be fluent in the clinical environment, comfortable in a room full of senior stakeholders and able to translate what a product does into what it is worth to the business that bought it. That person is rare, and the firms that understand it are already competing for them. The rest will find out at renewal.

Healthtech Hiring Advantages Have Moved Past the Model

Strip the noise out of a busy quarter and one thing clarifies. The winners in this next phase won't necessarily be the teams with the best model. As AI capabilities become increasingly accessible, the advantage is shifting towards what wraps around the technology: clinical validation, auditability, workflow design that lives inside the EHR and the human layer that earns a clinician's trust. That reorders a hiring plan.

Clinical and regulatory talent stops being a late-stage hire. Product managers who can build inside a clinical workflow rather than beside it become worth more than another model engineer. And customer success stops being a support function and becomes critical to whether a merged platform keeps the customers it just paid for. Read most of the scepticism in this market and you find an adoption problem wearing a technology costume. Adoption is a human problem long before it is a technical one.

The three talent priorities for healthtech leaders:

1. Hire regulatory and quality expertise earlier AI-enabled products need regulatory and quality input much earlier in the product lifecycle.

2. Prioritise clinical workflow experience Product leaders need to understand how technology actually fits into clinical environments.

3. Treat Customer Success as a growth function Retention and adoption increasingly depend on people who can bridge technology, clinical users and commercial outcomes.

Building or scaling a digital health team? Connect with our specialist HealthTech team for a clear view of the talent market and the expertise needed to support your next stage of growth.